Cited by 664Adipokines, Inflammation, and Metabolic DiseasesLipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Rutter, Martin K., Meigs, James B., Sullivan, Lisa M., D’Agostino, Ralph B., Wilson, Peter W.F.·2004·Circulation

DOI 10.1161/01.cir.0000136581.59584.0e

Open this paper in CoChat — free account

Abstract

Background— Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results— We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively ( P trend <0.0001). In persons with MetS, age-adjusted CRP levels were higher in women than men (7.8 versus 4.6 mg/L; P <0.0001). MetS and baseline CRP were individually related to CVD events (for MetS: age-sex-adjusted hazard ratio [HR], 2.1; 95% CI, 1.5 to 2.8; for highest versus lowest CRP quartile: HR, 2.2; 95% CI, 1.4 to 3.5). Greater risk of CVD persisted for MetS and CRP even after adjustment in a model including age, sex, MetS (HR, 1.8; 95% CI, 1.4 to 2.5), and CRP (HR, 1.9; 95% CI, 1.2 to 2.9). The c-statistic associated with the age- and sex-adjusted model including CRP was 0.72; including MetS, 0.74; and including CRP and MetS, 0.74. Conclusions— Elevated CRP levels are related to insulin resistance and the presence of the MetS, especially in women. Although discrimination of subjects at risk of CVD events using both MetS and CRP is not better than using either phenotype alone, both CRP and MetS are independent predictors of new CVD events.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000136581.59584.0e

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citation
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citation
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042

Show all 36 references

Research works printed but not linked: 7

10.1161/atvb.19.4.972 · DOI
10.1161/circ.102.1.42 · DOI
10.1161/str.32.11.2575 · DOI
1998, Diabetologia, 4, 1241
2003, Clin Chem Lab Med, 41, 1120
10.1210/jcem.86.9.7873 · DOI · Paper page
10.1001/jama.1991.03460050081025 · DOI

Sorted by citations

The metabolic syndrome
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
The metabolic syndrome
Eckel, R. H., Grundy, S. M., & Zimmet, P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66378-7 · Cited by 5,755
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,400
“(74) also found that CRP and the metabolic syndrome were independent risk factors, but in contrast to the two other reports, combining CRP and metabolic syndrome did not improve the predictive value of either used alone.”
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
Gami, A. S., Witt, B. J., Howard, D. E., Erwin, P. J., Gami, L. A., Somers, V. K., & Montori, V. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.032 · Cited by 1,888
Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome
Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1769 · Cited by 1,718
“For seven studies (13,15,18,19,21,23,24) with eight estimates of relative risk that excluded participants with diabetes or Figure 1—A: Associations between metabolic syndrome, using the NCEP definition, and all-cause mortality.”
Background
The Metabolic Syndrome
Grundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,227
Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
Galassi, A., Reynolds, K., & He, J. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.031 · Cited by 1,228
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & HEISS, G. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,051
Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study
Wilson, P. W. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1068 · Cited by 4
“Other laboratory measurements included levels of fasting and 2-hour OGTT insulin (determined using a commercially available assay [DPC Coat-a-Count; Diagnostics Products Corporation, Los Angeles, Calif]), total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and C-reactive protein (determined…”
MethodSelf-citation
Insulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
Lloyd-Jones, D. M. (2010) · Circulation · doi:10.1161/circulationaha.109.849166 · Cited by 705
Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
Wannamethee, S. G., Shaper, A. G., LENNON, L. T., & Morris, R. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2644 · Cited by 667
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease
Baker, A. R., da Silva, N. F., Quinn, D. W., Harte, A. L., Pagano, D., Bonser, R. S., Kumar, S., & McTernan, P. G. (2006) · Cardiovascular Diabetology · doi:10.1186/1475-2840-5-1 · Cited by 646
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C. J., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 641
C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk
Ridker, P. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.052 · Cited by 635
Energy intake is associated with endotoxemia in apparently healthy men
Amar, J., Burcelin, R., Ruidavets, J. B., Cani, P. D., Fauvel, J., Alessi, M., Chamontin, B., & Ferrières, J. (2008) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1219 · Cited by 610
The metabolically healthy but obese individual presents a favorable inflammation profile
Karelis, A. D., Faraj, M., Bastard, J.-P., St-Pierre, D. H., Brochu, M., Prud’homme, D., & Rabasa-Lhoret, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0482 · Cited by 579
“This finding is in line with previous studies that suggest that CRP levels could be an important factor associated with variations in insulin sensitivity (7, 9, 24).”
Result
High-Sensitivity C-Reactive Protein and Cardiovascular Disease
Yousuf, O. K., Mohanty, B. D., Martin, S. S., Joshi, P. H., Blaha, M. J., Nasir, K., Blumenthal, R. S., & Budoff, M. J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.016 · Cited by 505
Gender differences in the metabolic syndrome and their role for cardiovascular disease
Regitz‐Zagrosek, V., Lehmkuhl, E., & Weickert, M. O. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0351-5 · Cited by 462
“Increased CRP and metabolic syndrome were independent predictors of cardiovascular disease [62], and the relationship of elevated CRP to cardiovascular events was stronger in women than in men [62].”
Background
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 421
“Metabolic syndrome, characterized by a core set of disorders, including abdominal obesity, dyslipidemia, hypertension, and hyperglycemia, has been shown to be an important predictor of type 2 diabetes (1–4) and of cardiovascular disease (1,5,6).”
BackgroundSelf-citation
Association between dietary fiber and serum C-reactive protein
Ma, Y., Griffith, J. A., Chasan-Taber, L., Olendzki, B. C., Jackson, E., Stanek, E. J., Li, W., Pagoto, S. L., Hafner, A. R., & Ockene, I. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.760 · Cited by 396
Metabolic syndrome and cardiovascular disease
Qiao, Q., Gao, W., Zhang, L., Nyamdorj, R., & Tuomilehto, J. O. (2007) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456307780480963 · Cited by 383
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
Sundström, J., Risérus, U., Byberg, L., Zethelius, B., Lithell, H., & Lind, L. (2006) · BMJ · doi:10.1136/bmj.38766.624097.1f · Cited by 375
The metabolic syndrome: time for a critical appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 384
“drome, and incident cardiovascular events [68, 73, 74].”
Medical Treatment of Advanced Testicular Cancer
Feldman, D. R. (2008) · JAMA · doi:10.1001/jama.299.6.672 · Cited by 374
Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review
Kloppenborg, R. P., van den Berg, E., Kappelle, L. J., & Biessels, G. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.049 · Cited by 368
“Insulin resistance is thought to play a central role in the underlying pathophysiological mechanism of the metabolic syndrome, but recent reports show that inflammation may also be involved (Rutter et al., 2004).”
Background
Inflammatory Markers and the Metabolic Syndrome
Koh, K. K., Han, S. H., & Quon, M. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.082 · Cited by 374
An Assessment of Incremental Coronary Risk Prediction Using C-Reactive Protein and Other Novel Risk Markers
Folsom, A. R., Chambless, L. E., Ballantyne, C. M., Coresh, J., HEISS, G. M., Wu, K. K., Boerwinkle, E., Mosley, T. H., Sorlie, P. D., Diao, G., et al. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.13.1368 · Cited by 357
“74.(22) The Rotterdam Study reported an AUC of 0.”
Background
Increased coronary‐artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factors
Chung, C. P., Oeser, A. M., Raggi, P., Gebretsadik, T. S., Shintani, A., Sokka, T., Pincus, T., Avalos, I., & Stein, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21288 · Cited by 356
Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Association between dietary fiber and markers of systemic inflammation in the Women's Health Initiative Observational Study
Ma, Y., Hébert, J. R., Li, W., Bertone‐Johnson, E. R., Olendzki, B. C., Pagoto, S., Tinker, L. F., Rosal, M. C., Ockene, I. S., Ockene, J. K., et al. (2008) · Nutrition · doi:10.1016/j.nut.2008.04.005 · Cited by 350
Cardiovascular Disease Risk Assessment: Insights from Framingham
D’Agostino, R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013) · Global Heart · doi:10.1016/j.gheart.2013.01.001 · Cited by 350
Self-citation
Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events
Laryea, M. A., Watt, K. D. S., Molinari, M., Walsh, M. J., McAlister, V. C., Marotta, P. J., Nashan, B., & Peltekian, K. M. (2007) · Liver Transplantation · doi:10.1002/lt.21126 · Cited by 316
“Although the presence of any of the 4 cardinal features of metabolic syndrome in an individual is a risk factor for cardiac morbidity,(4) it has been well documented that the presence of 3 or more is associated with a higher incidence of cardiovascular complications.(5,6) As posttransplantation survival improves, card…”
Background
Magnesium Intake, C-Reactive Protein, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women
Song, Y., Ridker, P. M., Manson, J. E., Cook, N. R., Buring, J. E., & Liu, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1438 · Cited by 315
The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns
Wang, J., Ruotsalainen, S., Moilanen, L., Lepisto, P., Laakso, M., & Kuusisto, J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehl524 · Cited by 318
C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization
Timpson, N. J., Nordestgaard, B. G., Harbord, R. M., Zacho, J., Frayling, T. M., Tybjærg-Hansen, A., & Davey Smith, G. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.137 · Cited by 310
Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and Stroke: A Population-Based Cohort Study
Dregan, A., Charlton, J., Chowienczyk, P., & Gulliford, M. C. (2014) · Circulation · doi:10.1161/circulationaha.114.009990 · Cited by 303
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2060-x · Cited by 294
Insulin Resistance, the Metabolic Syndrome, and Risk of Incident Cardiovascular Disease
Jeppesen, J., Hansen, T. W., Rasmussen, S. L., Ibsen, H., Torp-Pedersen, C. T., & Madsbad, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.088 · Cited by 286
Cardiovascular Outcomes in Framingham Participants With Diabetes
Chen, G., McAlister, F. A., Walker, R. L., Hemmelgarn, B. R., & Campbell, N. R. C. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162446 · Cited by 291
Narrative Review: Assessment of C-Reactive Protein in Risk Prediction for Cardiovascular Disease
Lloyd‐Jones, D. M., Liu, K., Tian, L., & Greenland, P. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-1-200607040-00129 · Cited by 272
“Studies show significant correlations of CRP with burden of established risk factors (34, 35) and with the metabolic syndrome (36), and CRP level also correlates significantly with the Framingham risk score (33).”
Background
Ethnic Differences in C-Reactive Protein Concentrations
Kelley-Hedgepeth, A., Lloyd‐Jones, D. M., Colvin, A. B., Matthews, K. A., Johnston, J. M., Sowers, M. R., Sternfeld, B., Pasternak, R. C., Chae, C. U., & for the SWAN Investigators (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.098996 · Cited by 259
“Interestingly, a growing number of studies in non-white Asian populations have found that CRP concentrations in the upper quartile for that population are significantly associated with risk of diabetes/metabolic syndrome (24–28), despite being lowerthantheconcentrationsassociatedwiththesame diseases in white ( 29 , 30…”
Background
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors
Chung, C. P., Avalos, I., Oeser, A. M., Gebretsadik, T. S., Shintani, A., Raggi, P., & Stein, C. M. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054973 · Cited by 258
Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study
Mancia, G., Bombelli, M., Corrao, G., Facchetti, R., Madotto, F., Giannattasio, C., Trevano, F. Q., Grassi, G. M., Zanchetti, A., & Sega, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000251933.22091.24 · Cited by 252
Burnout and Risk of Type 2 Diabetes: A Prospective Study of Apparently Healthy Employed Persons
Melamed, S., Shirom, A., Toker, S., & Shapira, I. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000242860.24009.f0 · Cited by 248
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
LIAO, Y., TAKASHIMA, S., MAEDA, N., OUCHI, N., KOMAMURA, K., SHIMOMURA, I., HORI, M., MATSUZAWA, Y., FUNAHASHI, T., & KITAKAZE, M. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.018 · Cited by 236
“The metabolic syndrome (MetS) has been identified as a constellation of important risk factors for cardiovascular disease (CVD) [1,2].”
Background
Metabolic Syndrome among Adults in China - The 2010 China Noncommunicable Disease Surveillance
Lu, J., Wang, L., Li, M., Xu, Y., Jiang, Y., Wang, W., Li, J., Mi, S., Zhang, M., Yichong, L., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2477 · Cited by 239
Inflammation and Race and Gender Differences in Computerized Tomography‐measured Adipose Depots
Beasley, L. E., Koster, A., Newman, A. B., Javaid, M. K., Ferrucci, L., Kritchevsky, S. B., Kuller, L. H., Pahor, M., Schaap, L. A., Visser, M., et al. (2009) · Obesity · doi:10.1038/oby.2008.627 · Cited by 234
“Increased concentrations of IL-6, CRP, and TNF-α have been associated with higher risk of heart failure (5), lower insulin sensitivity (6), and metabolic syndrome (7,8), among other conditions.”
Background
The metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 233
“This survey included 3037 men and women aged 26 to 82 years who were followed up for 7 years (190) The metabolic syndrome was diagnosed by NCEPATP III criteria.”
Method
C-reactive protein is a mediator of cardiovascular disease
Bisoendial, R. J., Boekholdt, S. M., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq238 · Cited by 230
Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity
Polotsky, V. Y., Patil, S. P., Savransky, V., Laffan, A. M., Bevans‐Fonti, S., Frame, L. A., Steele, K., Schweizter, M. A., Clark, J. M., Torbenson, M. S., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-608oc · Cited by 218
Association of C-Reactive Protein With Blood Pressure and Hypertension
Smith, G. D., Lawlor, D. A., Harbord, R. M., Timpson, N. J., Rumley, A., Lowe, G. D. O., Day, I. N. M., & Ebrahim, S. B. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160351.95181.d0 · Cited by 212
Metabolic syndrome as a risk factor for neurological disorders
Farooqui, A. A., Farooqui, T., Panza, F., & Frisardi, V. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0840-1 · Cited by 213
“However, several pathways involving endothelial dysfunction [15], arterial stiffness [16] and inflammation may contribute to hypertension [17].”
Background
A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes
Kapiotis, S., Holzer, G., Schaller, G., Haumer, M., Widhalm, H., Weghuber, D., Jilma, B., Röggla, G., Wolzt, M., Widhalm, K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000245795.08139.70 · Cited by 205
YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
Rathcke, C. N., & Vestergaard, H. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-61 · Cited by 204
Impact of Metabolic Syndrome on the Development of Cardiovascular Disease in a General Japanese Population
Ninomiya, T., Kubo, M., Doi, Y., Yonemoto, K., Tanizaki, Y., Rahman, M. M., Arima, H., Tsuryuya, K., Iida, M., & Kiyohara, Y. (2007) · Stroke · doi:10.1161/strokeaha.106.479642 · Cited by 199
Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women
The DECODE Study Group, & Qiao, Q. (2006) · Diabetologia · doi:10.1007/s00125-006-0438-6 · Cited by 202
Clustering of Insulin Resistance With Vascular Dysfunction and Low-Grade Inflammation in Type 2 Diabetes
Natali, A., Toschi, E., Baldeweg, S. E., Ciociaro, D., Favilla, S., Saccà, L., & Ferrannini, E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1076 · Cited by 200
Inflammation and the Incidence of Type 2 Diabetes
Bertoni, A. G., Burke, G. L., Owusu, J. A., Carnethon, M. R., Vaidya, D. M., Barr, R. G., Jenny, N. S., Ouyang, P., & Rotter, J. I. (2010) · Diabetes Care · doi:10.2337/dc09-1679 · Cited by 207
A Prospective Study of Inflammatory Cytokines and Diabetes Mellitus in a Multiethnic Cohort of Postmenopausal Women
Liu, S. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1676 · Cited by 198
Chronic Inflammatory Diseases and Endothelial Dysfunction
Castellon, X., & Bogdanova, V. (2016) · Aging and disease · doi:10.14336/ad.2015.0803 · Cited by 191
Effects of a 12‐week exercise training programme on aerobic fitness, body composition, blood lipids and C‐reactive protein in adolescents with obesity
Wong, P. C., Chia, M. Y., Tsou, I. Y., Wansaicheong, G. K., Tan, B., Wang, J. C., Tan, J., Kim, C. G., Boh, G., & Lim, D. (2008) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.v37n4p286 · Cited by 191
The Metabolic Syndrome, Insulin Resistance, and Cardiovascular Risk in Diabetic and Nondiabetic Patients
Saely, C. H., Aczél, S., Marte, T., Langer, P. H., Hoefle, G., & Drexel, H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0799 · Cited by 187
Mediterranean diet and metabolic syndrome: the evidence
Babió, N., Bulló, M., & Salas‐Salvadó, J. (2009) · Public Health Nutrition · doi:10.1017/s1368980009990449 · Cited by 188
“Results from the West of Scotland Coronary Prevention Study (WOSCOPS) (92) , the Women’s Health Study (WHS) (93) and the Framingham Offspring Study (94) suggest that CRP adds clinically important prognostic information concerning MetS and cardiovascular risk.”
Distributions of C-Reactive Protein and its Association With Metabolic Syndrome in Middle-Aged and Older Chinese People
Ye, X., Yu, Z., Li, H., Franco, O. H., Liu, Y., & Xu, L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.065 · Cited by 177
Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk
van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S. G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00007 · Cited by 165
Markers of inflammation and their clinical significance
Ballantyne, C. M., & Nambi, V. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.02.005 · Cited by 168
AJC Editor's Consensus: Psoriasis and Coronary Artery Disease
Friedewald, V. E., Cather, J. C., Gelfand, J. M., Gordon, K. B., Gibbons, G. H., Grundy, S. M., Jarratt, M., Krueger, J. G., Ridker, P. M., Stone, N. J., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.004 · Cited by 163
Metabolic Syndrome and Cardiovascular Disease in Older People: The Cardiovascular Health Study
McNeill, A. M., Katz, R., Girman, C. J., Rosamond, W. D., Wagenknecht, L. E., Barzilay, J. I., Tracy, R. P., Savage, P. J., & Jackson, S. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00862.x · Cited by 163
Toll-like receptors regulate B cell cytokine production in patients with diabetes
Jagannathan, M., McDonnell, M., Liang, Y., Hasturk, H., Hetzel, J., Rubin, D., Kantarci, A., Van Dyke, T. E., Ganley-Leal, L. M., & Nikolajczyk, B. S. (2010) · Diabetologia · doi:10.1007/s00125-010-1730-z · Cited by 156
“CRP C-reactive protein GM-CSF Granulocyte/macrophage colony stimulating factor LPS Lipopolysaccharide MFI Mean fluorescence intensity ND Non-diabetic ODN Oligodeoxynucleotide Pam3 Pam3CSK4 PD Periodontal disease rLPS Rhodobacter sphaeroides lipopolysaccharide TLR Toll-like receptor M. Jagannathan Department of Patholo…”
BackgroundInfluential
High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation
Majhail, N. S., Flowers, M. E. D., Ness, K. K., Jagasia, M., Carpenter, P. A., Arora, M., Arai, S., Johnston, L., Martin, P. J., Baker, K. S., et al. (2008) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.263 · Cited by 149
Impaired Lung Function Is Associated with Obesity and Metabolic Syndrome in Adults
Lin, W., Yao, C., Wang, H., & Huang, K. (2006) · Obesity · doi:10.1038/oby.2006.190 · Cited by 150
“(46) have found, for example, that elevated CRP levels are related to metabolic syndrome.”
Background
Dietary Cholesterol from Eggs Increases Plasma HDL Cholesterol in Overweight Men Consuming a Carbohydrate-Restricted Diet ,2
Mutungi, G., Ratliff, J. C., Puglisi, M. J., Torres‐Gonzalez, M., Vaishnav, U., Leite, J. O. M., Quann, E. E., Volek, J. S., & Fernández, M. L. (2008) · Journal of Nutrition · doi:10.1093/jn/138.2.272 · Cited by 151
Metabolic Syndrome
Eberly, L. E., Prineas, R., Cohen, J. D., Vazquez, G., Zhi, X., Neaton, J. D., & Kuller, L. H. (2006) · Diabetes Care · doi:10.2337/diacare.29.1.123 · Cited by 164
Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats
Al‐Rasheed, N. M., Al-Rasheed, N. M., Hasan, I. H., Alamin, M. A., Al‐Ajmi, H. N., Mohamad, R. A., & Mahmoud, A. M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1092015 · Cited by 144
“Elevated CRP in STZ-induced diabetic rats in the present investigation was in agreement with the findings of previous studies showing increased serum CRP levels in diabetic patients [62] and STZ-induced type 1 diabetic animals [63].”
Result
Cardiovascular Disease in U.S. Patients With Metabolic Syndrome, Diabetes, and Elevated C-Reactive Protein
Malik, S., Wong, N. D., Franklin, S. S., Pio, J. R., Fairchild, C., & Chen, R. K. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.690 · Cited by 144
“(16), who recently demonstrated in the Framingham Heart Study that both CRP and metabolic syndrome (inclusive of diabetes) are independent predictors of new CVD events.”
Background
Metabolic Syndrome: Definition and Therapeutic Implications
Prasad, H., Ryan, D. A., Celzo, M. F., & Stapleton, D. D. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2514 · Cited by 142
Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts
Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 138
Metabolic syndrome and risk for heart failure in middle-aged men
Ingelsson, E., Ärnlöv, J., Lind, L., & Sundström, J. (2006) · Heart · doi:10.1136/hrt.2006.089011 · Cited by 139
Insulin Resistance and Risk Factors for Cardiovascular Disease in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Oeffinger, K. C., ADAMS-HUET, B. A., Victor, R. G., Church, T. S., Snell, P. G., Dunn, A. L., Eshelman‐Kent, D. A., Ross, R., Janiszewski, P. M., Turoff, A. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.7251 · Cited by 130
“among women in the general population is associated with insulin resistance and metabolic syndrome.(36) Notably, a CRP of 3 mg/L or higher in women has an additive effect when combined with metabolic syndrome in predicting future cardiovascular events.”
Background
Plasma Levels of High-Density Lipoprotein Cholesterol and Outcomes in Pulmonary Arterial Hypertension
Heresi, G. A., Aytekin, M., Newman, J. E., DiDonato, J. A., & Dweik, R. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0007oc · Cited by 128
Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men
Pischon, T., Hu, F. B., Rexrode, K. M., Girman, C. J., Manson, J. E., & Rimm, E. B. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.06.022 · Cited by 122
The Metabolic Syndrome as a Concept of Adipose Tissue Disease
Oda, E. (2008) · Hypertension Research · doi:10.1291/hypres.31.1283 · Cited by 120
Glycoprotein Acetyls: A Novel Inflammatory Biomarker of Early Cardiovascular Risk in the Young
Chiesa, S. T., Charakida, M., Georgiopoulos, G., Roberts, J. D., Stafford, S. J., Park, C. M., Mykkänen, J., Kähönen, M. A. P., Lehtimäki, T. J., Ala‐Korpela, M., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024380 · Cited by 118
“Our findings show that (1) GlycA is a stable marker of chronic inflammation which potentially lies downstream of different immune- related pathways to that underlying CRP, (2) that GlycA is associated with a wide- range of well- established lifestylerelated CVD risk factors for cardiovascular disease even at this earl…”
Low‐grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study
Jacobs, M., van Greevenbroek, M. M. J., Kallen, C., Ferreira, I., Blaak, E. E., Feskens, E. J. M., Jansen, E. H. J. M., Schalkwijk, C., & Stehouwer, C. D. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02129.x · Cited by 114
Epidemiology of the Metabolic Syndrome
Reynolds, K., & He, J. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00004 · Cited by 111
Serum antibodies to periodontal pathogens and markers of systemic inflammation
Dye, B. A., Choudhary, K., Shea, S., & Papapanou, P. N. (2005) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00856.x · Cited by 113
High prevalence of metabolic syndrome in patients with ankylosing spondylitis
Malesci, D., Niglio, A., Mennillo, G., Buono, R., Valentini, G., & MONTAGNA, G. L. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0380-5 · Cited by 109
“Moreover, some studies have pointed out a relationship among some CV risk factors or MetS and inflammation [ 10 , 11].”
Background
Physical activity, exercise and low-grade systemic inflammation
Wärnberǵ, J., Cunningham, K., Romeo, J., & Marcos, A. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110001928 · Cited by 111
“Furthermore, CRP levels are more strongly related to insulin resistance and the individual components of the metabolic syndrome in women than in men((78)).”
Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats
Gupta, S. K., Dongare, S., Mathur, R., Mohanty, I. R., Srivastava, S., Mathur, S. R., & Nag, T. C. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2483-2 · Cited by 107
Metabolic Consequences of Sleep-Disordered Breathing
Jun, J. C., & Polotsky, V. Y. (2009) · ILAR Journal · doi:10.1093/ilar.50.3.289 · Cited by 107
Serum C-reactive protein as a marker for wellness assessment.
Kao, P. C., Shiesh, S. C., & Wu, T. J. (2006) · PubMed · Cited by 101
Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk
Kressel, G., Trunz, B., Bub, A., Hülsmann, O., Wolters, M., Lichtinghagen, R., Stichtenoth, D. O., & Hahn, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.012 · Cited by 101
Time-Restricted Eating and Metabolic Syndrome: Current Status and Future Perspectives
Świątkiewicz, I., Woźniak, A., & Taub, P. R. (2021) · Nutrients · doi:10.3390/nu13010221 · Cited by 106
The Metabolic Syndrome Is Associated With Circulating Adipokines in Older Adults Across a Wide Range of Adiposity
You, T., Nicklas, B. J., Ding, J., Penninx, B. W. J. H., Goodpaster, B. H., Bauer, D. C., Tylavsky, F. A., Harris, T. B., Kritchevsky, S. B., & for the Health, A. A. B. C. S. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.4.414 · Cited by 101
Dietary Epicatechin Promotes Survival of Obese Diabetic Mice and Drosophila melanogaster
Si, H., Fu, Z., Babu, P. V. A., Wei, Z. C., LeRoith, T., Meaney, M. P., Voelker, K. A., Jia, Z., Grange, R. W., & Liu, D. (2011) · Journal of Nutrition · doi:10.3945/jn.110.134270 · Cited by 101
Predictors of cardiovascular events after liver transplantation
Coss, E., Watt, K. D. S., Pedersen, R. A., Dierkhising, R., Heimbach, J. K., & Charlton, M. (2010) · Liver Transplantation · doi:10.1002/lt.22140 · Cited by 100
Obstructive sleep apnea syndrome is a systemic disease. Current evidence
Zamarrón, C., García-Paz, V., & Riveiro, A. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.12.006 · Cited by 100
“inflammation with major implications for cardiovascular morbidity and atherogenesis [126,127] is increased in OSAS in accordance with disease severity [128–130].”
Background
Acute Phase Reactants as Novel Predictors of Cardiovascular Disease
Ahmed, M. S., Jadhav, A. B., Hassan, A. J., & Meng, Q. H. (2012) · ISRN Inflammation · doi:10.5402/2012/953461 · Cited by 104
“As well, it adds a prognostic information on vascular risk at all levels of the metabolic syndrome [44].”
Background
Extraintestinal manifestations ofHelicobacter pylori: A concise review
Wong, F. T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i34.11950 · Cited by 104

Authors: Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F.
Affiliations: Boston University (US)
ORCID: Rutter, Martin K.
Meigs, James B.
Sullivan, Lisa M.
D’Agostino, Ralph B.
Wilson, Peter W.F.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-07-27
Volume: 110
Issue: 4
Pages: 380-385
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000136581.59584.0e
OpenAlex: W1983997573
Cited by: 664
References: 36
Citations by year: 2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 19 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 36 · 2013: 36 · 2012: 26
FWCI: 48.38
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Research Explorer (The University of Manchester) (submittedVersion)
Funders: National Institutes of Health (n01hc25195-41-0-1)
National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, R01-HL 073272-01)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: C-reactive protein, metabolic syndrome, cardiovascular risk prediction, inflammation, insulin resistance, sex differences, Framingham Offspring Study, cardiovascular events, risk discrimination, cardiovascular risk in women, NCEP ATP III criteria, Framingham risk score, Framingham risk equation
MeSH terms: Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cardiovascular Diseases, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk, Sex Factors, Cohort Studies, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks